FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Valium (diazepam) from Roche Laboratories Inc., updating the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Muscle Spasm
• Seizure Disorders
• Status Epilepticus

Drugs mentioned

• VALIUM (DIAZEPAM)

Snippet

SUPPL AP for VALIUM (DIAZEPAM)